Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Meyronet

Showing results (101-110 of 136) with videos related to

Pageof 14
Sort By:
Acta Neuropathologica|August 31, 2016
Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohortEmeline Tabouret, Anh Tuan Nguyen, Caroline Dehais, et al.
Neuro-Oncology Advances|May 30, 2024
TARGET: A phase I/II open-label multicenter study to assess safety and efficacy of fexagratinib in patients with relapsed/refractory FGFR fusion-positive gliomaAlberto Picca, Anna Luisa Di Stefano, Julien Savatovsky, et al.
Neuropathology and Applied Neurobiology|March 16, 2022
Rosette-forming glioneuronal tumours are midline, FGFR1-mutated tumoursRomain Appay, Franck Bielle, Philipp Sievers, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 24, 2025
Detection of fungal pathogens by a histomolecular approach using targeted-massive parallel sequencing on formalin-fixed tissues: a retrospective studyAlexis Trecourt, Meja Rabodonirina, Marie Donzel, et al.
Neuro-Oncology|February 13, 2018
Identification of novel recurrent ETV6-IgH fusions in primary central nervous system lymphomaAurélie Bruno, Karim Labreche, Maïlys Daniau, et al.
Medical Oncology (Northwood, London, England)|November 5, 2021
Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trialAlice Bonneville-Levard, Didier Frappaz, Olivier Tredan, et al.
Neuro-Oncology|August 11, 2022
Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network studyAntoine Seyve, Caroline Dehais, Olivier Chinot, et al.
Journal of Neuropathology and Experimental Neurology|January 26, 2008
Assessment of alpha-synuclein pathology: a study of the BrainNet Europe ConsortiumIrina Alafuzoff, Laura Parkkinen, Safa Al-Sarraj, et al.
Acta Neuropathologica|March 18, 2008
Inter-laboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the BrainNet Europe consortiumIrina Alafuzoff, Maria Pikkarainen, Thomas Arzberger, et al.
Brain Pathology (Zurich, Switzerland)|July 27, 2021
An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterpartsArnault Tauziède-Espariat, Philipp Sievers, Frédérique Larousserie, et al.
Pageof 14

Showing results (101-110 of 136) with videos related to

Sort By:
Pageof 14
Acta Neuropathologica|August 31, 2016
Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohortEmeline Tabouret, Anh Tuan Nguyen, Caroline Dehais, et al.
Neuro-Oncology Advances|May 30, 2024
TARGET: A phase I/II open-label multicenter study to assess safety and efficacy of fexagratinib in patients with relapsed/refractory FGFR fusion-positive gliomaAlberto Picca, Anna Luisa Di Stefano, Julien Savatovsky, et al.
Neuropathology and Applied Neurobiology|March 16, 2022
Rosette-forming glioneuronal tumours are midline, FGFR1-mutated tumoursRomain Appay, Franck Bielle, Philipp Sievers, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 24, 2025
Detection of fungal pathogens by a histomolecular approach using targeted-massive parallel sequencing on formalin-fixed tissues: a retrospective studyAlexis Trecourt, Meja Rabodonirina, Marie Donzel, et al.
Neuro-Oncology|February 13, 2018
Identification of novel recurrent ETV6-IgH fusions in primary central nervous system lymphomaAurélie Bruno, Karim Labreche, Maïlys Daniau, et al.
Medical Oncology (Northwood, London, England)|November 5, 2021
Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trialAlice Bonneville-Levard, Didier Frappaz, Olivier Tredan, et al.
Neuro-Oncology|August 11, 2022
Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network studyAntoine Seyve, Caroline Dehais, Olivier Chinot, et al.
Journal of Neuropathology and Experimental Neurology|January 26, 2008
Assessment of alpha-synuclein pathology: a study of the BrainNet Europe ConsortiumIrina Alafuzoff, Laura Parkkinen, Safa Al-Sarraj, et al.
Acta Neuropathologica|March 18, 2008
Inter-laboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the BrainNet Europe consortiumIrina Alafuzoff, Maria Pikkarainen, Thomas Arzberger, et al.
Brain Pathology (Zurich, Switzerland)|July 27, 2021
An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterpartsArnault Tauziède-Espariat, Philipp Sievers, Frédérique Larousserie, et al.
Pageof 14